Director proposes sale of 450 MSCI shares under Form 144 (NYSE: MSCI)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
MSCI filed a Form 144 reporting the proposed sale of 450 shares of Common Stock by Andrew Craig Wiechmann. The filing lists the securities as Performance and Restricted Stock with a grant date of 02/05/2024 and shows a sale date of 03/17/2026 and aggregate proceeds of $252,000.00.
Positive
- None.
Negative
- None.
Key Figures
Form type: Form 144
Shares proposed for sale: 450 shares
Aggregate proceeds: $252,000.00
+2 more
5 metrics
Form type
Form 144
notice of proposed sale
Shares proposed for sale
450 shares
Common Stock proposed sale
Aggregate proceeds
$252,000.00
Proceeds tied to sale dated <date>03/17/2026</date>
Grant date
02/05/2024
Performance and Restricted Stock grant date
Sale date
03/17/2026
Date shown for securities sold during past 3 months
Key Terms
Form 144, Performance and Restricted Stock, Issuer
3 terms
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Performance and Restricted Stock financial
"Performance and Restricted Stock | ISSUER"
Issuer regulatory
"Performance and Restricted Stock | ISSUER"
FAQ
What does MSCI's Form 144 filed for MSCI mean?
It notifies the SEC of a proposed sale of restricted stock by an insider. The filing shows 450 shares of Performance and Restricted Stock and a proposed sale dated 03/17/2026 by Andrew Craig Wiechmann, with aggregate proceeds of $252,000.00.
What proceeds are shown for the proposed sale in the Form 144?
The Form 144 lists aggregate proceeds of $252,000.00 for the proposed sale. That dollar amount is associated with the 450 shares reported as sold on 03/17/2026 in the filing excerpt provided.
What type of securities are being sold according to the MSCI Form 144?
The securities are identified as Performance and Restricted Stock. The filing ties those securities to a grant date of 02/05/2024 and lists the broker/placement details shown in the excerpt for the proposed sale.